SEC Form 4 · accession 0001235802-17-000149
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy B Petrick
Officer — VP, Research & Development
Period of report
Sep 22, 2017
Accepted (ET)
Sep 26, 2017 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF2 | Sep 22, 2017 | S | 2,000 | $18.00 | D | 94,385 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- F2Includes an aggregate of 933 shares acquired under the Entellus Medical, Inc. 2015 Employee Stock Purchase Plan on June 30, 2016, December 31, 2016 and June 30, 2017.